License from advanced bioadjuvants LLC to produce their patented adjuplex adjuvants. (ambis #2063418)
Ended Purchase Order Awarded Last action
- Contract number
- 75N93021P01385
- Awardee
-
Advanced Bioadjuvants, LLC UEI F9TBLFL9A3C3
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $225,000
Award facts
- Opportunity
-
- Advanced Bioadjuvant LLC’s Adjuplex adjuvants for use with vaccines against infectious diseases Pre-Solicitation · NIAIDNOI212063418 · Posted Jul 26, 2021
- Contract value 60% obligated
-
- $225,000.00 Current, with exercised options
- $375,000.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Omaha, NE 68135, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $75,000 | |
| Exercise an Option | $75,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $75,000 |
About this award
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $375,000 firm fixed price purchase order to Advanced Bioadjuvants, LLC of Omaha, Nebraska. The three-year contract, running from September 2021 through September 2024, provides a non-exclusive license to Advanced Bioadjuvants' Adjuplex adjuvant technology. This will allow the National Institute of Allergy and Infectious Diseases to manufacture cGMP grade material and clinically evaluate Adjuplex with vaccines against human infectious diseases, as described in the original sole source solicitation notice. As a small business, Advanced Bioadjuvants qualifies for the set-aside designation under the NAICS code 541714 for research and development in biotechnology. No major subcontractors were identified.
Quick answers
Who was awarded contract 75N93021P01385?
75N93021P01385 was awarded to Advanced Bioadjuvants, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 26, 2021.
How much is contract 75N93021P01385 worth?
The government has obligated $225,000 on 75N93021P01385. Its potential value, with all options, is $375,000.
Was contract 75N93021P01385 competed?
The extent of competition for 75N93021P01385 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award